Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 71 results for "Myelodysplastic Syndromes (MDS)".

Thumbnail for Synergistic Epigenetic-Cohesin Disruption in Myelodysplastic Syndromes: ASXL1/STAG2 Defines an Ultra-High-Risk Phenotype Amenable to BCL-2 Inhibition

MDS - 717

Synergistic Epigenetic-Cohesin Disruption in Myelodysplastic Syndromes: ASXL1/STAG2 Defines an Ultra-High-Risk Phenotype Amenable to BCL-2 Inhibition

Yazan Abushukair

Poster Presenter: Yazan Abushukair

Thumbnail for Danicopan Add-On Therapy to Ravulizumab or Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis Stratified by Bone Marrow Failure History

MDS - 748

Danicopan Add-On Therapy to Ravulizumab or Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis Stratified by Bone Marrow Failure History

Ying Tang

Poster Presenter: Ying Tang

Previous 1...4 5 6 7 8 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Comparative Efficacy and Safety of Oral Azacitidine (CC-486) Versus Injectable Hypomethylating Agents as Maintenance Therapy Following Allogeneic Haematopoietic Cell Transplantation in Myelodysplastic Neoplasms: A Systematic Review and Network Meta-Analysis

MDS - 749

Comparative Efficacy and Safety of Oral Azacitidine (CC-486) Versus Injectable Hypomethylating Agents as Maintenance Therapy Following Allogeneic Haematopoietic Cell Transplantation in Myelodysplastic Neoplasms: A Systematic Review and Network Meta-Analysis

Abhinav M

Poster Presenter: Abhinav M

Thumbnail for Real-World Outcomes With Early Adoption of Imetelstat in Patients With Transfusion-Dependent Myelodysplastic Syndromes (MDS): Insights From a United States (US) Community Oncology Chart Review

MDS - 775

Real-World Outcomes With Early Adoption of Imetelstat in Patients With Transfusion-Dependent Myelodysplastic Syndromes (MDS): Insights From a United States (US) Community Oncology Chart Review

Jessy Thomas

Poster Presenter: Jessy Thomas

Thumbnail for Leukemic Transformation and Clinical Outcomes in Thrombocytopenic Myelodysplastic Syndrome Patients Treated with Thrombopoietin Receptor Agonists: A Real-World TriNetX Cohort Study

MDS - 782

Leukemic Transformation and Clinical Outcomes in Thrombocytopenic Myelodysplastic Syndrome Patients Treated with Thrombopoietin Receptor Agonists: A Real-World TriNetX Cohort Study

Madhu Bhargavi Chandra

Poster Presenter: Madhu Bhargavi Chandra

Thumbnail for Rising Burden of Anemia in Myelodysplastic Syndromes: A 25-Year U.S. Mortality and Disparities Study

MDS - 786

Rising Burden of Anemia in Myelodysplastic Syndromes: A 25-Year U.S. Mortality and Disparities Study

Muhammad Ibrahim

Poster Presenter: Muhammad Ibrahim

Thumbnail for Risk-Stratified Survival and Treatment Patterns in MDS: A Nationwide Analysis from the Spanish Group of Myelodysplastic Syndromes (GESMD)

MDS - 790

Risk-Stratified Survival and Treatment Patterns in MDS: A Nationwide Analysis from the Spanish Group of Myelodysplastic Syndromes (GESMD)

Ra?l Azibeiro Melchor

Poster Presenter: Ra?l Azibeiro Melchor

Thumbnail for Sustained Long-Term Control of Terminal Complement Activity With Ravulizumab or Danicopan Add-On to Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

MDS - 794

Sustained Long-Term Control of Terminal Complement Activity With Ravulizumab or Danicopan Add-On to Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

Pennie Moore

Poster Presenter: Pennie Moore

Thumbnail for Palliative Care Integration in Transfusion-Dependent Myelodysplastic Syndromes: A Real-World Propensity-Matched TriNetX Cohort Study

MDS - 800

Palliative Care Integration in Transfusion-Dependent Myelodysplastic Syndromes: A Real-World Propensity-Matched TriNetX Cohort Study

Fathima Shehnaz Ayoobkhan

Poster Presenter: Fathima Shehnaz Ayoobkhan

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors